Neurosurgery Devices Market By Device Type (Neuroendoscope, Stereotactic Systems, Aneurysm Clips, Neurostimulation Devices, Cerebrospinal Fluid Management Devices, Neurosurgical Evacuation Device, Neurosurgical Navigation Systems, Neurosurgery Surgical Power Tools, Others) - Growth, Future Prospects And Competitive Analysis, 2018 – 2026

The global neurosurgery devices market held US$ 12,454.2 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. The market is set to grow during the forecast period owing to influx of novel neurosurgical devices and growing inclination towards minimally invasive surgeries. Moreover, growing incidences of spinal disorders, traumatic injuries and endovascular surgeries are few of the major factors for the growth of the market. Rising prevalence and procedures related to brain tumors are also expected to drive the market for neurosurgery devices market. 

According to National Brain Tumor Society, it is projected that 78,980 new cases of malignant and non-malignant brain tumor and CNS tumors were be diagnosed in the U.S. in 2018. Growing cases of brain aneurysm is further expected to assist the market growth. As per estimates by Brain Aneurysm Foundation, 6 million people in the United States of 1 in 50 people have an unruptured brain aneurysm. Rising life expectancy and aging population will further increase the prevalence of various neurological disorders, thereby driving the market of neurosurgery devices market. Established market players such as Medtronic, Intergra LifeSciences, Aesculap have a broader product portfolios are focusing on development of minimally invasive surgical devices, while new entrants and niche players like Vycor and NICO Corporation are focusing innovative products.

"Minimally Invasive Neurosurgical Devices to Drive the Market"

Cerebrospinal fluid management devices and neurostimulation devices held a significant share in neurosurgery devices market and expected to drive the market through the forecast period. The growth is driven by innovation in these segments, for instance, uptake of antimicrobial CSF management devices and minimally invasive procedures drive the market. Minimally invasive neurosurgical devices have also been proven to improve patient outcomes, reduce hospitalization and overall cost of the procedure. Devices like NICO’ Myriad and Penumbra Apollo neurosurgical evacuation devices can successfully remove intracranial hemorrhage using minimally invasive technique. Neuroendscopes and aneurysm clips will exhibit a tremendous growth during the forecast period. However, requirement of high skill training, and availability of these devices in emerging countries will act as major hindrance to the market.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

Neurosurgery Devices market report furnishes quantitative analysis along with its latest market trends. The market is segmented based on device type and geography.

Market is studied in order to understand the current dynamics and future trends in the global neurosurgery devices market. The study includes market size and forecast for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rate (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year. The key players currently engaged in neurosurgery devices market include Medtronic PLC, B. Braun Melsungen AG, Stryker Corporation, Boston Scientific Corporation, DePuy Synthes, Inc., Integra LifeSciences, Biotronic among others.